Skip to content

Most contraceptives not linked to HIV infection, but Depo-Provera may raise risk

Ongoing hepatitis B virus replication associated with higher mortality for people with HIV

Menan Gérard Kouamé presenting at AIDS 2016. Photo by Liz Highleyman, hivandhepatitis.com

Vaginal bacteria increase HIV susceptibility and may reduce PrEP effectiveness

Salim Abdool Karim presenting at AIDS 2016. Photo by Jan Brittenson, hivandhepatitis.com

Most people taking second-line ART in sub-Saharan Africa achieve viral suppression but there's a need for third-line treatment options

No new HIV infections seen in San Francisco's Strut PrEP programme

Pierre-Cedric Crouch presenting at AIDS 2016. Photo by Liz Highleyman, hivandhepatitis.com

Efavirenz appears to be associated with elevated suicide risk in START trial

Alejandro Arenas-Pinto presenting at AIDS 2016. Photo by Liz Highleyman, hivandhepatitis.com

A detectable CMV viral load could signal a high risk of mortality in older individuals hospitalised with HIV-associated TB

sqofield/Shutterstock.com

People shifting from paediatric to adult HIV care have a high risk of ART failure

Package of prophylaxis against infections reduces the risk of death for people starting HIV treatment very late

Prof James Hakim presents results of the REALITY trial. Photo by Liz Highleyman, hivandhepatitis.com